These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 8574773
1. [Parathyroid hormone related peptide (PTHrP) and bone metabolism]. Rouffet J, Barlet JP. Arch Physiol Biochem; 1995 Apr; 103(1):3-13. PubMed ID: 8574773 [Abstract] [Full Text] [Related]
2. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Amizuka N, Karaplis AC, Henderson JE, Warshawsky H, Lipman ML, Matsuki Y, Ejiri S, Tanaka M, Izumi N, Ozawa H, Goltzman D. Dev Biol; 1996 Apr 10; 175(1):166-76. PubMed ID: 8608863 [Abstract] [Full Text] [Related]
3. A novel parathyroid hormone-related protein: role in pathology and physiology. Martin TJ, Ebeling PR. Prog Clin Biol Res; 1990 Apr 10; 332():1-37. PubMed ID: 2184438 [Abstract] [Full Text] [Related]
4. [Parathyroid hormone related-protein and calcium homeostasis]. Riond JL, Kocabagli N, Toromanoff A, Wanner M. Schweiz Arch Tierheilkd; 1995 Apr 10; 137(4):117-23. PubMed ID: 7660095 [Abstract] [Full Text] [Related]
5. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA. Cancer Res; 1997 Aug 01; 57(15):3194-9. PubMed ID: 9242449 [Abstract] [Full Text] [Related]
6. Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts. Evely RS, Bonomo A, Schneider HG, Moseley JM, Gallagher J, Martin TJ. J Bone Miner Res; 1991 Jan 01; 6(1):85-93. PubMed ID: 2048435 [Abstract] [Full Text] [Related]
12. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors. Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E. Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357 [Abstract] [Full Text] [Related]
14. Functional analysis of the PTH/PTHrP network of ligands and receptors. Kronenberg HM, Lanske B, Kovacs CS, Chung UI, Lee K, Segre GV, Schipani E, Jüppner H. Recent Prog Horm Res; 1998 Jun 01; 53():283-301; discussion 301-3. PubMed ID: 9769712 [Abstract] [Full Text] [Related]
15. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocaña A, Bisello A, Hollis BW, Rosen CJ, Wysolmerski JJ, Dann P, Gundberg C, Stewart AF. J Bone Miner Res; 2005 Oct 01; 20(10):1792-803. PubMed ID: 16160737 [Abstract] [Full Text] [Related]
17. Stromal cells are critical targets in the regulation of mammary ductal morphogenesis by parathyroid hormone-related protein. Dunbar ME, Young P, Zhang JP, McCaughern-Carucci J, Lanske B, Orloff JJ, Karaplis A, Cunha G, Wysolmerski JJ. Dev Biol; 1998 Nov 01; 203(1):75-89. PubMed ID: 9806774 [Abstract] [Full Text] [Related]